Humanigen, Inc.: Humanigen to Present and Participate at Multiple Investor Events in March
Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' announced today that management will present